Posted:
8/3/2025, 7:42:22 PM
Location(s):
Cologne, North Rhine-Westphalia, Germany ⋅ North Rhine-Westphalia, Germany
Experience Level(s):
Senior
Field(s):
Finance & Banking ⋅ Sales & Account Management
Abbott Rapid Diagnostics GmbH in Cologne is looking for a Senior Regional Finance Manager DACH + Netherlands (m/f/d).
We are recruiting for our next Commercial Controller, ARDx Infectious Disease DACH & Netherlands based in our office in Cologne, Germany.
The primary function of this position is to execute a wide range of financial planning and decision support responsibilities, including short and long-range planning and execution of strategic initiatives, for Abbott Rapid Diagnostics Infectious Disease EMEA region, with responsibility for Germany, Switzerland, Austria and the Netherlands. This role will be responsible for the full range of finance responsibilities in the region (e.g., general accounting in conjunction with Global Shared Services, financial planning, financial reporting, financial analysis, cost accounting, entity reporting, internal control, entity planning, inventory control, and disbursements) to ensure the timeliness, accuracy, and integrity of all financial related information.
What You’ll Work On
Qualifications:
Follow your career aspirations to Abbott for diverse opportunities with a company that can help you build your future and live your best life. Abbott is an Equal Opportunity Employer, committed to employee diversity.
We ask for your understanding that we only consider online applications via our online application portal. Applications by email or post cannot be processed. Original documents will not be returned.
Connect with us at www.abbott.com, on LinkedIn at https://www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
The base pay for this position is
N/AIn specific locations, the pay range may vary from the range posted.
Website: https://abbott.com/
Headquarter Location: Illinois City, Illinois, United States
Employee Count: 1001-5000
Year Founded: 1944
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Emergency Medicine ⋅ Genetics ⋅ Health Care ⋅ Health Diagnostics ⋅ Manufacturing ⋅ Medical ⋅ Medical Device ⋅ Nutrition ⋅ Pharmaceutical